ID   DEGS2_HUMAN             Reviewed;         323 AA.
AC   Q6QHC5; Q6P492;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   24-NOV-2009, sequence version 2.
DT   15-MAR-2017, entry version 107.
DE   RecName: Full=Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2;
DE            EC=1.14.18.5 {ECO:0000269|PubMed:15063729};
DE            EC=1.14.19.17 {ECO:0000269|PubMed:15063729};
DE   AltName: Full=Degenerative spermatocyte homolog 2;
DE   AltName: Full=Sphingolipid 4-desaturase;
DE   AltName: Full=Sphingolipid C4-monooxygenase;
GN   Name=DEGS2 {ECO:0000312|HGNC:HGNC:20113}; Synonyms=C14orf66;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, TISSUE SPECIFICITY,
RP   INDUCTION, AND VARIANT ASN-8.
RC   TISSUE=Skin {ECO:0000312|EMBL:AAS68362.1};
RX   PubMed=15063729; DOI=10.1016/S0014-5793(04)00274-1;
RA   Mizutani Y., Kihara A., Igarashi Y.;
RT   "Identification of the human sphingolipid C4-hydroxylase, hDES2, and
RT   its up-regulation during keratinocyte differentiation.";
RL   FEBS Lett. 563:93-97(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S.,
RA   Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C.,
RA   Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P.,
RA   Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N.,
RA   Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C.,
RA   Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S.,
RA   Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B.,
RA   Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M.,
RA   Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S.,
RA   Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D.,
RA   Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A.,
RA   Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L.,
RA   Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J.,
RA   Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W.,
RA   Quetier F., Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ASN-8.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-57.
RC   TISSUE=Skin {ECO:0000312|EMBL:AAH63598.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Bifunctional enzyme which acts as both a sphingolipid
CC       delta(4)-desaturase and a sphingolipid C4-monooxygenase.
CC       {ECO:0000269|PubMed:15063729}.
CC   -!- CATALYTIC ACTIVITY: A dihydroceramide + 2 ferrocytochrome b5 +
CC       O(2) + 2 H(+) = a (4R)-4-hydroxysphinganine ceramide + 2
CC       ferricytochrome b5 + H(2)O. {ECO:0000269|PubMed:15063729}.
CC   -!- CATALYTIC ACTIVITY: A dihydroceramide + 2 ferrocytochrome b5 +
CC       O(2) + 2 H(+) = a (4E)-sphing-4-enine ceramide + 2 ferricytochrome
CC       b5 + 2 H(2)O. {ECO:0000269|PubMed:15063729}.
CC   -!- PATHWAY: Membrane lipid metabolism; sphingolipid biosynthesis.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8R2F2}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:Q8R2F2}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in skin, intestine and
CC       kidney. {ECO:0000269|PubMed:15063729}.
CC   -!- INDUCTION: Up-regulated during keratinocyte differentiation. Not
CC       expressed at day 0 or day 3 after differentiation, detected on day
CC       6 and increases by day 9. {ECO:0000269|PubMed:15063729}.
CC   -!- SIMILARITY: Belongs to the fatty acid desaturase type 1 family.
CC       DEGS subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY541700; AAS68362.1; -; mRNA.
DR   EMBL; AL133523; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471061; EAW81688.1; -; Genomic_DNA.
DR   EMBL; BC063598; AAH63598.1; -; mRNA.
DR   CCDS; CCDS9956.1; -.
DR   RefSeq; NP_996801.2; NM_206918.2.
DR   UniGene; Hs.159643; -.
DR   ProteinModelPortal; Q6QHC5; -.
DR   STRING; 9606.ENSP00000307126; -.
DR   SwissLipids; SLP:000000170; -.
DR   iPTMnet; Q6QHC5; -.
DR   PhosphoSitePlus; Q6QHC5; -.
DR   BioMuta; DEGS2; -.
DR   DMDM; 269849561; -.
DR   PaxDb; Q6QHC5; -.
DR   PeptideAtlas; Q6QHC5; -.
DR   PRIDE; Q6QHC5; -.
DR   Ensembl; ENST00000305631; ENSP00000307126; ENSG00000168350.
DR   GeneID; 123099; -.
DR   KEGG; hsa:123099; -.
DR   UCSC; uc001ygx.3; human.
DR   CTD; 123099; -.
DR   DisGeNET; 123099; -.
DR   GeneCards; DEGS2; -.
DR   H-InvDB; HIX0037711; -.
DR   HGNC; HGNC:20113; DEGS2.
DR   HPA; HPA046644; -.
DR   MIM; 610862; gene.
DR   neXtProt; NX_Q6QHC5; -.
DR   OpenTargets; ENSG00000168350; -.
DR   PharmGKB; PA134973300; -.
DR   eggNOG; KOG2987; Eukaryota.
DR   eggNOG; ENOG410XQVT; LUCA.
DR   GeneTree; ENSGT00390000013448; -.
DR   HOGENOM; HOG000188299; -.
DR   HOVERGEN; HBG052775; -.
DR   InParanoid; Q6QHC5; -.
DR   KO; K04712; -.
DR   OMA; WFFCTPA; -.
DR   OrthoDB; EOG091G09NW; -.
DR   PhylomeDB; Q6QHC5; -.
DR   TreeFam; TF313582; -.
DR   BioCyc; MetaCyc:HS15665-MONOMER; -.
DR   BRENDA; 1.14.13.169; 2681.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00786; -.
DR   GenomeRNAi; 123099; -.
DR   PRO; PR:Q6QHC5; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000168350; -.
DR   CleanEx; HS_DEGS2; -.
DR   ExpressionAtlas; Q6QHC5; baseline and differential.
DR   Genevisible; Q6QHC5; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042284; F:sphingolipid delta-4 desaturase activity; IBA:GO_Central.
DR   GO; GO:0000170; F:sphingosine hydroxylase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006667; P:sphinganine metabolic process; IEA:Ensembl.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; TAS:Reactome.
DR   InterPro; IPR011388; DES1/DES2.
DR   InterPro; IPR005804; FA_desaturase_dom.
DR   InterPro; IPR013866; Sphingolipid_d4-desaturase_N.
DR   Pfam; PF00487; FA_desaturase; 1.
DR   Pfam; PF08557; Lipid_DES; 1.
DR   PIRSF; PIRSF017228; Sphnglp_dlt4_des; 1.
DR   SMART; SM01269; Lipid_DES; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Lipid biosynthesis;
KW   Lipid metabolism; Lipoprotein; Membrane; Myristate; Oxidoreductase;
KW   Polymorphism; Reference proteome; Transmembrane; Transmembrane helix.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q564G3}.
FT   CHAIN         2    323       Sphingolipid delta(4)-desaturase/C4-
FT                                monooxygenase DES2.
FT                                {ECO:0000250|UniProtKB:Q564G3}.
FT                                /FTId=PRO_0000312816.
FT   TRANSMEM     45     65       Helical. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical. {ECO:0000255}.
FT   TRANSMEM    210    231       Helical. {ECO:0000255}.
FT   REGION       95     99       Required for C4-hydroxylase activity.
FT                                {ECO:0000250|UniProtKB:Q8R2F2}.
FT   MOTIF        89     93       Histidine box-1. {ECO:0000305}.
FT   MOTIF       128    132       Histidine box-2. {ECO:0000305}.
FT   MOTIF       259    263       Histidine box-3. {ECO:0000305}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000250|UniProtKB:Q564G3}.
FT   VARIANT       8      8       S -> N (in dbSNP:rs7157599).
FT                                {ECO:0000269|PubMed:15063729,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_060347.
FT   VARIANT      57     57       A -> T (in dbSNP:rs4905937).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_055698.
SQ   SEQUENCE   323 AA;  37197 MW;  4726A4EBD357EB0F CRC64;
     MGNSASRSDF EWVYTDQPHT QRRKEILAKY PAIKALMRPD PRLKWAVLVL VLVQMLACWL
     VRGLAWRWLL FWAYAFGGCV NHSLTLAIHD ISHNAAFGTG RAARNRWLAV FANLPVGVPY
     AASFKKYHVD HHRYLGGDGL DVDVPTRLEG WFFCTPARKL LWLVLQPFFY SLRPLCVHPK
     AVTRMEVLNT LVQLAADLAI FALWGLKPVV YLLASSFLGL GLHPISGHFV AEHYMFLKGH
     ETYSYYGPLN WITFNVGYHV EHHDFPSIPG YNLPLVRKIA PEYYDHLPQH HSWVKVLWDF
     VFEDSLGPYA RVKRVYRLAK DGL
//
